Managing editor Tim Elfrink
Managing editor Tim Elfrink

New Times' Biogenesis Series Finalist for Harvard's Goldsmith Award

Miami New Times managing editor Tim Elfrink's series about the Biogenesis anti-aging clinic, which resulted in the suspension of 13 Major League Baseball players including Yankees slugger Alex Rodriguez, has been named one of six finalists for the Goldsmith Award in Political Journalism from the Shorenstein Center on Media, Politics and Public Policy at Harvard's Kennedy School of Government.

We are up against stiff competition for the prize, which pays $25,000 for a top entry and $10,000 for finalists, which include one story that took "112 journalists and 42 media partners in 58 countries."

See also: Tony Bosch and the MLB Biogenesis Steroid Scandal

There's a joint investigation by ABC News and the Center for Public Integrity on black lung disease; an enormous project by the International Consortium of Investigative Journalists on offshore tax havens; a bilingual series about rape in the fields by the Investigative Reporting Program (IRP) at UC Berkeley's School of Journalism, the Center for Investigative Reporting (CIR), Frontline, Univisión Documentaries, and KQED; a Milwaukee Journal Sentinel series about blood testing delays; and a Wall Street Journal series on lobotomies.

"Thrilling," said Alex S. Jones, director of the Shorenstein Center. "The finalists this year are emblematic of the future of journalism."

Follow Miami New Times on Facebook and Twitter @MiamiNewTimes.


All-access pass to the top stories, events and offers around town.

  • Top Stories


All-access pass to top stories, events and offers around town.

Sign Up >

No Thanks!

Remind Me Later >